Skip to main content
Intermediate Technical IVT

CHA2DS2-VASc Score

Pronunciation: CHADS-two-VAS-see

Also written as: CHA2DS2-VASc — Congestive heart failure, Hypertension, Age ≥75, Diabetes, Stroke, Vascular disease, Age 65-74, Sex category

A clinical prediction rule for estimating stroke risk in patients with atrial fibrillation, particularly relevant for anticoagulation decisions in elderly patients.

Full Definition

The CHA2DS2-VASc score is a validated risk stratification tool used to assess thromboembolic risk in patients with atrial fibrillation. The acronym stands for Congestive heart failure, Hypertension, Age ≥75 years (2 points), Diabetes, Stroke/TIA (2 points), Vascular disease, Age 65-74 years, and Sex category (female). In geriatric cardiology, this score is particularly important as advanced age significantly increases stroke risk, with patients aged 75 and older receiving 2 points. The score guides anticoagulation decisions, with most elderly patients having scores warranting anticoagulation therapy. However, bleeding risk must be balanced against thromboembolic risk using tools like the HAS-BLED score.

Usage

Usage note: Note the subscript '2' and ensure proper calculation including age-specific point allocation.

In Context

  • "The patient's CHA2DS2-VASc score of 4 indicated high stroke risk warranting anticoagulation therapy." — Anticoagulation assessment
  • "Given the CHA2DS2-VASc score calculation, the geriatrician recommended initiating direct oral anticoagulation." — Treatment recommendation

Also known as

CHADS-VASc score

Contrasted with

HAS-BLED score

Don't confuse with

CHADS2 score HAS-BLED score

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON